QLINE2026-04-012026-06-30QLINE2026-06-30QLINE2026-03-31xbrli:pure000000QLINENOTLISTEDINE1G2W01011Q-LINE BIOTECH LIMITED2026-04-012027-03-31Quarterly2026-06-30SMEfalseIt is to infomed that in accordance with Regulation 15(2) of the SEBI (LODR) Regulations, 2015, (as amended), the Compliance with the Corporate Governance provisions as specified in regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 26A, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V shall not apply, in respect of a listed entity which has listed its specified securities on the SME Exchange. Provided that with effect from April 01, 2025, the provisions of regulation 23 shall be applicable in respect of a listed entity which has listed its specified securities on the SME Exchange and which has either paid up equity share capital exceeding Rupees ten crore or net worth exceeding Rupees twenty-five crore, as on the last day of the previous financial year. Since, Q-Line Biotech Limited ("the Company") is a SME Listed Entity, hence the requirement w.r.t., the Compliance Report on Corporate Governance is not applicable to the Company, except Regulation 23 of SEBI (LODR) Regulations, 2015, (as amendedtruefalseNot Applicable for the Quarter ended on June 30, 2026, since, no acquisition of shares or voting rights in unlisted companies during the quarter ended on June 30, 2026, in terms of sub-para 1 of para A of Part A of Schedule III of the SEBI (LODR) Regulations, 2015, (as amended), was made/done/perform/scheduled.falseNot Applicable for the Quarter ended on June 30, 2026, since, there have been no action(s) taken nor orders passed by any regulatory, statutory, enforcement authority, or judicial body against the listed entity, its directors, key managerial personnel, senior management, promoters, or subsidiaries, in relation to the listed entity, concerning any of the following matters: (a) Suspension; (b) Imposition of fines or penalties; (c) Settlement of proceedings; (d) Debarment; (e) Disqualification; (f) Closure of operations; (g) Imposition of sanctions; (h) Issuance of warnings or cautions; or (i) Any other similar actions, regardless of the terminology used." during the quarter ended on June 30, 2026, in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (LODR) Regulations, 2015, (as amended).falseNot Applicable for the Quarter ended on June 30, 2026, since, there were no pending litigation(s) or dispute(s), nor any outcomes thereof, that could have a impact on the listed entity, in terms of sub-para 8 of para B of Part A of Schedule III of the SEBI (LODR) Regulations, 2015, (as amended).truecomq00036Original00000